Innovative Gastroscope Enhances Imaging Capabilities

The Fuse 1G Gastroscope employs Full Spectrum Endoscopy technology using two cameras, while traditional systems have just one camera. This allows observation of nearly twice as much surface area, allowing clinicians to identify adenomas or precancerous lesions in and behind the folds that occur naturally in the colon and stomach anatomy, problem areas that can easily go undetected when using traditional endoscopes. Optimal imaging is enabled using built-in light emitting diode (LED) lighting around the tip to provide illumination.

Images are displayed on three high-definition (HD) screens, allowing visualization of more of the GI tract. The system uses a FuseBox control unit with the FusePanel image management system to interface with electronic medical record (EMR) systems for tracking of patients, physician IDs, and the procedures performed. It also enables saving of every image for viewing or printing later. Images can be captured remotely or can be exported in PDF format to be used on other EMR systems. The Fuse 1G Gastroscope is a product of EndoChoice (Atlanta, GA, USA), and has been approved by the US Food and Drug Administration (FDA).

“We are 100% focused on serving the GI professionals so they can give the best possible care to their patients,” said Mark Gilreath, founder and CEO of EndoChoice. “This clearance by the FDA is yet another milestone in our efforts to make the Fuse system available to more hospitals and clinics.”

“We have a national colorectal cancer screening program in the United States wherein most people should get screened for colorectal cancer, but not all patients follow these guidelines,” said Prof. Douglas K. Rex, MD, of Indiana University (Indianapolis, USA). “The data from the Full Spectrum Endoscopy Tandem study would indicate that Fuse is a radical improvement over the tools we've used in the past to fight GI disease.”

Related Links:
EndoChoice